1. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients
    Christopher K. C. Lai et al, 2022, Microbiology Spectrum CrossRef
  2. Disorders of intestinal microbiocenosis: expanding the application of probiotics
    D. I. Trukhan, 2022, Meditsinskiy sovet = Medical Council CrossRef
  3. Ongoing Treatment with a Spore-Based Probiotic Containing Five Strains of Bacillus Improves Outcomes of Mild COVID-19
    Adrian Catinean et al, 2023, Nutrients CrossRef
  4. SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies
    Shanji Liu et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
  5. Pharmacological Efficacy of Probiotics in Respiratory Viral Infections: A Comprehensive Review
    Shadma Wahab et al, 2022, Journal of Personalized Medicine CrossRef
  6. Efficacy of a synbiotic in the management of adults with Attention-Deficit and Hyperactivity Disorder and/or Borderline Personality Disorder, and high levels of irritability: Results from a multicenter, randomized, placebo-controlled, “basket” trial
    Gara Arteaga-Henríquez et al, 2024, Brain, Behavior, and Immunity CrossRef
  7. Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines
    V. B. Grinevich et al, 2023, Experimental and Clinical Gastroenterology CrossRef
  8. Gut Microbiota and COVID-19: Potential Implications for Disease Severity
    Giulia Rocchi et al, 2022, Pathogens CrossRef
  9. Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics
    Leena Sapra et al, 2022, Inflammation Research CrossRef
  10. The salivary and nasopharyngeal microbiomes are associated with SARS‐CoV‐2 infection and disease severity
    Josh G. Kim et al, 2023, Journal of Medical Virology CrossRef
  11. Probiotics, their action modality and the use of multi-omics in metamorphosis of commensal microbiota into target-based probiotics
    Maryam Idrees et al, 2022, Frontiers in Nutrition CrossRef
  12. Administration of Ligilactobacillus salivarius CECT 30632 to elderly during the COVID-19 pandemic: Nasal and fecal metataxonomic analysis and fatty acid profiling
    Marta Mozota et al, 2022, Frontiers in Microbiology CrossRef
  13. Long COVID‐19 gastrointestinal related disorders and traditional Chinese medicine: A network target‐based approach
    Laura Beatrice Mattioli et al, 2024, Phytotherapy Research CrossRef
  14. The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection
    Antonia Piazzesi et al, 2024, Frontiers in Cellular and Infection Microbiology CrossRef
  15. Immunomodulatory Effects of Probiotics on COVID-19 Infection by Targeting the Gut–Lung Axis Microbial Cross-Talk
    Kalliopi D. Synodinou et al, 2022, Microorganisms CrossRef
  16. COVID-19 Therapeutic Potential of Natural Products
    Zhaoxuan Low et al, 2023, International Journal of Molecular Sciences CrossRef
  17. The extracellular polysaccharide inhibit porcine epidemic diarrhea virus with extract and gene editing Lacticaseibacillus
    Shaojun Chen et al, 2023, Microbial Cell Factories CrossRef
  18. Benefits of probiotic use on COVID-19: A systematic review and meta-analysis
    Suelen Neris Almeida Viana et al, 2024, Critical Reviews in Food Science and Nutrition CrossRef
  19. Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
    In-Chan Hwang et al, 2023, Microbial Cell Factories CrossRef